0001493152-23-031993.txt : 20230907 0001493152-23-031993.hdr.sgml : 20230907 20230907170143 ACCESSION NUMBER: 0001493152-23-031993 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20230906 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230907 DATE AS OF CHANGE: 20230907 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lineage Cell Therapeutics, Inc. CENTRAL INDEX KEY: 0000876343 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943127919 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12830 FILM NUMBER: 231242967 BUSINESS ADDRESS: STREET 1: 2173 SALK AVENUE STREET 2: SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 5105213390 MAIL ADDRESS: STREET 1: 2173 SALK AVENUE STREET 2: SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 FORMER COMPANY: FORMER CONFORMED NAME: BIOTIME INC DATE OF NAME CHANGE: 19930328 8-K 1 form8-k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 6, 2023

Lineage Cell Therapeutics, Inc.

(Exact name of Registrant as Specified in Its Charter)

California

001-12830

94-3127919

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

2173 Salk Avenue, Suite 200

Carlsbad, California

94-92008

(Address of Principal Executive Offices)

(Zip Code)

(442) 287-8990

Registrant’s Telephone Number, Including Area Code

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common shares		LCTX		NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As described under Item 5.07 below, at the annual meeting of shareholders (the “Annual Meeting”) of Lineage Cell Therapeutics, Inc. (the “Company”) held on September 6, 2023, the Company’s shareholders approved an amendment (the “EIP Amendment”) to the Company’s 2021 Equity Incentive Plan (the “2021 Plan”), pursuant to which the number of common shares of the Company available for issuance under the 2021 Plan was increased by 19,500,000. The Company’s board of directors previously approved the EIP Amendment, subject to shareholder approval. A more complete description of the EIP Amendment and a summary of the 2021 Plan, as amended by the EIP Amendment, is in the Company’s definitive proxy statement for the Annual Meeting, which was filed with the U.S. Securities and Exchange Commission on July 27, 2023 (the “Proxy Statement”), and is incorporated herein by reference. The foregoing summary of the EIP Amendment is qualified in its entirety by reference to the EIP Amendment, a copy of which is filed as an exhibit to this report.

Item 5.07 Submission of Matters to a Vote of Security Holders.

The Annual Meeting was held on September 6, 2023. The matters voted upon at the Annual Meeting are described in detail in the Proxy Statement. Below is a brief description of each such matter and the final voting results, including the number of votes cast for, withheld or against, the number of abstentions and the number of broker non-votes with respect to each matter, as applicable.

Proposal 1. The Company’s shareholders elected the nine nominees named below to the Company’s board of directors to hold office until the Company’s 2024 annual meeting of shareholders and until their respective successors are duly elected and qualified by the following votes:

Nominee		Votes For				Votes Withheld				Broker Non-Votes
Dipti Amin			74,273,372				1,103,028				43,913,515
Deborah Andrews			74,096,073				1,280,327				43,913,515
Don Bailey			73,391,291				1,985,109				43,913,515
Neal C. Bradsher			73,396,208				1,980,192				43,913,515
Brian M. Culley			74,426,506				949,894				43,913,515
Alfred D. Kingsley			71,157,090				4,219,310				43,913,515
Anula Jayasuriya			73,404,130				1,972,270				43,913,515
Michael H. Mulroy			63,115,746				12,260,654				43,913,515
Angus C. Russell			55,755,116				19,621,284				43,913,515

-2-

Proposal 2. The Company’s shareholders ratified the appointment of WithumSmith+Brown, PC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, by the votes set forth below.

Votes For				Vote Against				Abstentions				Broker Non-Votes
	118,493,370				481,961				314,584				—

Proposal 3. The Company’s shareholders approved, on an advisory and non-binding basis, the compensation paid to the Company’s named executive officers, as set forth in the Proxy Statement, by the votes set forth below.

Votes For				Vote Against				Abstentions				Broker Non-Votes
	70,271,698				4,542,895				561,807				43,913,515

Proposal 4. The Company’s shareholders voted as follows with respect to the preferred frequency of holding an advisory vote on the compensation of the Company’s named executive officers.

Every Year				Every Two Years				Every Three Years				Abstentions				Broker Non-Votes
	71,622,410				983,734				975,224				1,795,032				43,913,515

Proposal 5. The Company’s shareholders approved the EIP Amendment by the votes set forth below.

Votes For				Vote Against				Abstentions				Broker Non-Votes
	66,175,977				8,543,323				657,100				43,913,515

Proposal 6. The Company’s shareholders approved an amendment to the Company’s restated articles of incorporation to increase the number of authorized common shares from 250,000,000 to 450,000,000 by the votes set forth below.

Votes For				Vote Against				Abstentions				Broker Non-Votes
	108,314,123				10,203,002				772,790				—

Proposal 7. The Company’s shareholders approved the adjournment of the Annual Meeting, if necessary or advisable, to solicit additional proxies in favor of Proposal 6 in the event there are not sufficient votes to approve Proposal 6 by the votes set forth below.

Votes For				Vote Against				Abstentions				Broker Non-Votes
	108,130,223				10,087,729				1,071,963				—

In light of the results on proposal 4, and consistent with the board of directors’ recommendation, the Company will include the shareholder advisory vote on named executive officer compensation in its proxy materials every year until the next required vote on the frequency of shareholder advisory votes on executive compensation.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
10.1*		Amendment to the Lineage Cell Therapeutics, Inc. 2021 Equity Incentive Plan
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

* Incorporated by reference from Appendix A to the Proxy Statement.

-3-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Lineage Cell Therapeutics, Inc.

Date: September 7, 2023	By:	/s/ George A. Samuel III
		George A. Samuel III
		General Counsel and Corporate Secretary

-4-

EX-101.SCH 2 lctx-20230906.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 lctx-20230906_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Information, Former Legal or Registered Name EX-101.PRE 4 lctx-20230906_pre.xml XBRL PRESENTATION FILE XML 5 R1.htm IDEA: XBRL DOCUMENT

Cover	Sep. 06, 2023
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Sep. 06, 2023
Entity File Number	001-12830
Entity Registrant Name	Lineage Cell Therapeutics, Inc.
Entity Central Index Key	0000876343
Entity Tax Identification Number	94-3127919
Entity Incorporation, State or Country Code	CA
Entity Address, Address Line One	2173 Salk Avenue
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Carlsbad
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94-92008
City Area Code	(442)
Local Phone Number	287-8990
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common shares
Trading Symbol	LCTX
Security Exchange Name	NYSEAMER
Entity Emerging Growth Company	false
Entity Information, Former Legal or Registered Name	Not Applicable

XML 6 form8-k_htm.xml IDEA: XBRL DOCUMENT 0000876343 2023-09-06 2023-09-06 iso4217:USD shares iso4217:USD shares 0000876343 false 8-K 2023-09-06 Lineage Cell Therapeutics, Inc. CA 001-12830 94-3127919 2173 Salk Avenue Suite 200 Carlsbad CA 94-92008 (442) 287-8990 Not Applicable false false false false Common shares LCTX NYSEAMER false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 24 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://lineagecell.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm lctx-20230906.xsd lctx-20230906_lab.xml lctx-20230906_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8-k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "contextCount": 1, "dts": { "inline": { "local": [ "form8-k.htm" ] }, "labelLink": { "local": [ "lctx-20230906_lab.xml" ] }, "presentationLink": { "local": [ "lctx-20230906_pre.xml" ] }, "schema": { "local": [ "lctx-20230906.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 60, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "LCTX", "nsuri": "http://lineagecell.com/20230906", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "AsOf2023-09-06", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://lineagecell.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "AsOf2023-09-06", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationFormerLegalOrRegisteredName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Former Legal or Registered Name of an entity", "label": "Entity Information, Former Legal or Registered Name" } } }, "localname": "EntityInformationFormerLegalOrRegisteredName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://lineagecell.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 13 0001493152-23-031993-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-031993-xbrl.zip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end